| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.03M | - | |
| Other | 21.6K | $1.43M | - | |
| Other | 15.4K | $1.02M | -5,538 | |
| Dir | 8.0K | $529.8K | - | |
| Dir | 8.0K | $529.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | Wilson Mark Andrew58 | SVP &General Counsel | Sale+OE | 5,344 | $19.45 | $103,940.80 | -6.3% | |
| Jan 28, 2021 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 75,000 | $18.62 | $1,396,500.00 | -29.8% | |
| Dec 15, 2020 | Myriam Curet56 | Director | Sell | 1,560 | $17.82 | $27,799.20 | -7.5% | |
| Nov 23, 2020 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 16,380 | $16.40 | $268,632.00 | -6.1% | |
| Nov 16, 2020 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 29,618 | $16.93 | $501,432.74 | -10.0% | |
| Nov 16, 2020 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 1,539 | $16.93 | $26,055.27 | -3.0% | |
| Nov 16, 2020 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 11,976 | $16.93 | $202,753.68 | -7.0% | |
| Nov 16, 2020 | Robin Howard W58 | President &CEO | Sell | 11,975 | $16.93 | $202,736.75 | -3.3% | |
| Nov 16, 2020 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 8,276 | $16.93 | $140,112.68 | -3.5% | |
| Sep 28, 2020 | Ajer Jeffrey Robert58 | Director | Sell | 3,250 | $17.25 | $56,062.50 | -11.1% |